Wedbush reiterates Outperform rating for Nuvation Bio, raises PT to $11.

viernes, 27 de marzo de 2026, 8:47 am ET1 min de lectura
NUVB--

Wedbush reiterates Outperform rating for Nuvation Bio, raises PT to $11.

Wedbush reiterates Outperform rating for Nuvation Bio, raises PT to $11.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios